Access cutting-edge breast cancer treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Springfield at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The Nanosomal Docetaxel Lipid Suspension (NDLS) consists of uniformly sized micro particles of docetaxel suspended in a lipid based formulation. The advantage of such a Lipid Based formulation of Docetaxel is an improvement of the safety profile by eliminating excipients, polysorbate 80 and ethanol which are present in conventional Docetaxel formulations (Taxotere®). This randomized, open-label study is designed to assess the efficacy and safety of Nanosomal Docetaxel Lipid Suspension at the dos
Sponsor: Jina Pharmaceuticals Inc.
Check if you qualify for this breast cancer clinical trial in Springfield, MO
If you're searching for breast cancer treatment options in Springfield, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.